Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Biotechnology
protextm.co

About Protext Mobility

On June 13th, 2022, Protext Mobility was acquired by RSAMMD. Terms of the transaction were not disclosed. Protext Mobility, operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (SA) and Cannabis Biosciences. The Company is engaged in the research and clinical testing of "bioceutical" products -- all natural ingredients formulated for pharmaceutical applications and processed under pharma-grade conditions.

Headquarters Location

2255 Glades Road

Boca Raton, Florida, 33431,

United States

(435) 881 3611

Want to inform investors similar to Protext Mobility about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Protext Mobility

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Protext Mobility in 1 Expert Collection, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest Protext Mobility News

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION

Nov 14, 2022

About Protext (OTC PINK: TXTM) Through its prior acquisitions, Protext has engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. Safe Harbor Statement This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward- looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward- looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.

Protext Mobility Acquisitions

1 Acquisition

Protext Mobility acquired 1 company. Their latest acquisition was Cannabis Biosciences on March 27, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/27/2017

$99M

Acquired

1

Date

3/27/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.